Bio-Rad Labs (BIO) Tops Q3 EPS by 85c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $355.23 -0.29%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $2.01, $0.85 better than the analyst estimate of $1.16. Revenue for the quarter came in at $649.7 million versus the consensus estimate of $628.18 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
- JPMorgan Upgrades America Movil (AMX) to Overweight
- XP Inc. (XP) Tops Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
